Patients with extra-adrenal malignancies and adrenal lesions have similar rates of subclinical hypercortisolism compared with patients with true adrenal incidentalomas
During follow-up in cancer patients, adrenal lesions are frequently found by computer tomography imaging. In these patients, the frequency of subclinical Cushing’s syndrome (SCS) has not been fully explored. The aim of the present study was to investigate the presence of SCS in cancer patients with adrenal lesions in comparison to patients with true adrenal incidentalomas.
We studied 95 patients with adrenal lesions: 57 patients (group A, 20 males and 37 females) had a history of extra-adrenal malignancy and adrenal lesions were discovered during staging of the primary cancer, and 38 patients (group B, 6 males and 32 females) had adrenal incidentalomas. The two groups had similar BMI. All patients had unenhanced HU < 10 in computed tomography to ensure low risk of adrenal metastatic disease. Patients’ morning plasma cortisol levels and ACTH were measured. An overnight 1 mg dexamethasone suppression test (ODST) was performed in all participants; in case of abnormal results, 24-h urine cortisol and the low-dose dexamethasone suppression test were additionally conducted. The cutoffs of morning cortisol values used for ODST were 1.8 and 5 μg/dl.
When the cutoff of 1.8 μg/dl for suppressed morning cortisol was used, 42.1% of group A and 39.5% of group B had abnormal results (p = 0.95). By using the threshold of 5 μg/dl after ODST, 5.3% of group A and 13.2% of group B did not have suppressed cortisol levels with the 1 mg ODST (p = 0.18). The main factors found to influence suppressed cortisol levels after ODST in both groups were BMI and size of the adrenal lesion.
Patients with extra-adrenal malignancies and adrenal lesions had similar rates of subclinical hypercortisolemia compared to patients with true adrenal incidentalomas.
KeywordsAdrenal incidentalomas Cancer Subclinical hypercortisolism
This research did not receive any specific grant from any funding agency.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 17.Zeiger MA, Thompson GB, Duh QY, American Association of Clinical Endocrinologists, American Association of Endocrine Surgeons et al (2009) American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the Management of Adrenal Incidentalomas: executive summary of recommendations. Endocr Pract 15:450–453CrossRefGoogle Scholar
- 19.van den Broek J, Geenen R, Heijnen L, Kobus C, Schreurs H (2018) Adrenal incidentalomas during diagnostic work-up of colorectal cancer patients: what is the risk of metastases? Ann Surg Oncol 25(7):1986–1991Google Scholar
- 21.Lissoni P, Brivio F, Fumagalli I et al (2007) Immune and endocrine mechanisms of advanced cancer-related hypercortisolemia. In Vivo 21:647–650Google Scholar
- 24.Kamijo K, Sato T, Sato M, Kawasaki K, Yashi A (1990) Fundamental and clinical studies of changes in endocrine conditions in cancer patients. Gan To Kagaku Ryoho 17(3 Pt 2):494–499Google Scholar